CD274 and neoplasm: In tumor cells, PD-L1 overexpression serves as an immune evasion mechanism by binding to PD-1 receptors on T lymphocytes, thereby suppressing T cell activation and cytotoxic function, ultimately allowing tumor cells to escape immune surveillance [5].